Addex Study Links mGlu7 Modulation To Sleep Regulation And Stress Neurochemistry
Geneva, Switzerland, July 8, 2026. Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN) has released fresh preclinical findings suggesting that one of its experimental compounds can shift how animals sleep and how their brains handle stress. The company, which builds small-molecule drugs called allosteric modulators for brain disorders, said the compound ADX71743 measurably changed sleep-wake patterns … Read more
